Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This trial studies the safety and immunogenicity of a HIV clade B\'/C DNA vaccine followed by recombinant vaccinia virus rTV boost in HIV-uninfected healthy volunteers at low or high risk of HIV infection. In addition, the effect of different intervals of the prime-boost will be studied.
Epistemonikos ID: a477c8a7f118592072e34983d2743e366f8e576f
First added on: Mar 23, 2020